Tech Company Financing Transactions

Tune Therapeutics Funding Round

On 12/3/2021, Tune Therapeutics raised $40 million in funding from Emerson Collective, New Enterprise Associates and Hatteras Venture Partners.

Transaction Overview

Company Name
Announced On
12/3/2021
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Proceeds Purpose
This financing will enable Tune to rapidly advance its preclinical research, attract top-tier talent, and further develop its therapeutic platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1616 Eastlake Ave. East
Seattle, WA 98102
USA
Phone
Undisclosed
Email Address
Overview
Tune Therapeutics, Inc. is orchestrating the power of the epigenome to treat complex, pervasive diseases that have long eluded treatment. With its versatile and powerful TEMPO epigenomic control platform, Tune's experienced team is pioneering a new therapeutic modality that can fine-tune any gene network.
Profile
Tune Therapeutics LinkedIn Company Profile
Social Media
Tune Therapeutics Company Twitter Account
Company News
Tune Therapeutics News
Facebook
Tune Therapeutics on Facebook
YouTube
Tune Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Matthew Kane
  Matthew Kane LinkedIn Profile  Matthew Kane Twitter Account  Matthew Kane News  Matthew Kane on Facebook
Chief Scientific Officer
Charles Gersbach
  Charles Gersbach LinkedIn Profile  Charles Gersbach Twitter Account  Charles Gersbach News  Charles Gersbach on Facebook
Co-Founder
Fyodor Urnov
  Fyodor Urnov LinkedIn Profile  Fyodor Urnov Twitter Account  Fyodor Urnov News  Fyodor Urnov on Facebook
Executive Vice President
Heidi Zhang
  Heidi Zhang LinkedIn Profile  Heidi Zhang Twitter Account  Heidi Zhang News  Heidi Zhang on Facebook
President
Akira Matsuno
  Akira Matsuno LinkedIn Profile  Akira Matsuno Twitter Account  Akira Matsuno News  Akira Matsuno on Facebook
VP - R & D
Blythe Sather
  Blythe Sather LinkedIn Profile  Blythe Sather Twitter Account  Blythe Sather News  Blythe Sather on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/3/2021: Goalsetter venture capital transaction
Next: 12/3/2021: Structure venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary